Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.

MLA

Kiykim, Ayca, et al. “Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.” The Journal of Allergy and Clinical Immunology. In Practice, vol. 7, no. 8, Nov. 2019, p. 2790. EBSCOhost, https://doi.org/10.1016/j.jaip.2019.06.011.

APA

Kiykim, A., Ogulur, I., Dursun, E., Charbonnier, L. M., Nain, E., Cekic, S., Dogruel, D., Karaca, N. E., Cogurlu, M. T., Bilir, O. A., Cansever, M., Kapakli, H., Baser, D., Kasap, N., Kutlug, S., Altintas, D. U., Al-Shaibi, A., Agrebi, N., Kara, M., … Baris, S. (2019). Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency. The Journal of Allergy and Clinical Immunology. In Practice, 7(8), 2790. https://doi.org/10.1016/j.jaip.2019.06.011

Chicago

Kiykim, Ayca, Ismail Ogulur, Esra Dursun, Louis Marie Charbonnier, Ercan Nain, Sukru Cekic, Dilek Dogruel, et al. 2019. “Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.” The Journal of Allergy and Clinical Immunology. In Practice 7 (8): 2790. doi:10.1016/j.jaip.2019.06.011.